Press release
Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific Officer and member of the management board
Martinsried, Germany, February 9, 2012. Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas.At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for the treatment of multiple sclerosis, and he led the team that discovered a selective S1P-receptor agonist, currently in Phase II for the same indication. As Life Cycle Leader at Roche he implemented an innovative development and commercial strategy for one of Roche´s leading late-stage development candidates that culminated in a multi-thousand patient clinical program in cardiovascular disease. Dr. Hinterding has led various international research & development collaborations and is an author and inventor of more than 20 patents and publications. He was a post-doctoral fellow at Harvard University and received his PhD in organic Chemistry from the University of Karlsruhe.
Torsten Neuefeind, founder and CEO of Proteros, said: “Klaus’ significant background in medicinal chemistry, drug discovery and clinical development will have an immediate impact on Proteros’ growing integrated lead discovery business. Klaus will be responsible for growing the organization that supports our clients as they rely on Proteros to deliver analytical services of crystallography, compound profiling, proteins and increasingly lead compounds, through innovative, integrated structure guided drug discovery collaborations. We welcome Klaus to Proteros.”
About Proteros biostructures GmbH:
Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables ‘knowledge driven lead engineering’ to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients’ internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. Proteros US, Inc. is a wholly owned subsidiary of Proteros established to serve the growing customer base in North America.
For further information please visit the website at: www.proteros.com
Proteros biostructures GmbH
Thomas Waldmann, Ph.D.
Bunsenstrasse 7a
D-82152, Martinsried
Germany
Phone: +49 89 7007 61 – 0
E-Mail: business@proteros.com
Internet: www.proteros.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Proteros announces the appointment of Dr. Klaus Hinterding as Chief Scientific Officer and member of the management board here
News-ID: 210335 • Views: …
More Releases from Proteros biostructures GmbH
PROTEROS ANNOUNCES SUCCESSFUL CLOSE OF FINANCING ROUND
Largest-ever Financing allows for Expansion of Drug Discovery Capabilities
MARTINSRIED, GERMANY (August 6th, 2012) – Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed a financing round of five million Euros to fund the continued expansion and growth of the company.
The financing round was led by BayBG, a key equity investor for Proteros. The financing round is the third and largest investment into the firm since the inception…
Proteros and Eisai Co., Ltd enter into Integrated Lead Discovery Collaboration
Martinsried (Germany), April 16, 2012. Proteros biostructures GmbH today announced that the company has entered into a research collaboration with Eisai Co., Ltd (Japan) to identify small molecule inhibitors against a target selected by Eisai in the field of immunology.
Under the agreement Proteros will deliver a novel lead compound applying its integrated lead discovery platform that includes X-Ray structural biology, biophysical screening and profiling, novel fragment libraries and medicinal chemistry…
Janssen Pharmaceutica NV and Proteros expand relationship and enter into Global …
Martinsried Jan 09, 2012. Janssen Research & Development, a division of Janssen Pharmaceutica NV (“Janssen”) and Proteros biostructures GmbH (“Proteros”) today announced they have entered into a long-term global service agreement granting Janssen privileged access to Proteros portfolio of discovery technologies and services.
Under the agreement Janssen will have broad access to Proteros’ drug discovery technologies, including structural biology, biophysical screening and profiling service, novel fragment libraries, medicinal chemistry expertise and…
More Releases for Klaus
Global Railway Power Cables Market 2018 - Klaus Faber, Glenair, L&T Metro Rail L …
Apex Market Reports, recently published a detailed market research study focused on the “Railway Power Cables Market” across the global, regional and country level. The report provides 360° analysis of “Railway Power Cables Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Railway…
Global Bromoethane Market 2017- Arkema, GFS Chemicals, Boc Sciences, Klaus F. Me …
Report covers Bromoethane global sales and global Bromoethane Market growth rate [2012 to 2022].
Below is the list of some key points of Bromoethane market report.
A] Bromoethane Market by Regions:-
1. USA Bromoethane market Status, Prospect (2012-2022)
2. China Bromoethane market Status, Prospect (2012-2022)
3. Europe Bromoethane market Status, Prospect (2012-2022)
4. Japan Bromoethane market Status, Prospect (2012-2022)
B] Worldwide Bromoethane Market Size (Value and Volume) [2012 to 2022].
C] Worldwide Bromoethane Manufacturers Analysis/Key Competitors :-
1 Arkema
2…
Klaus Sindel is Bühler Motor GmbH’s new Director Product Segment Industrial S …
Nuremberg, February 20, 2014 – Effective January 1, Klaus Sindel will assume the role of Bühler Motor GmbH’s Director Product Segment Industrial Solutions. He succeeds Randy Davis, who returned to the US to see to a continued successful positioning of Bühler Motor’s North-American subsidiary as Buehler Motor, Inc.’s Director Sales & Marketing Industrial & Healthcare.
These changes further strengthen Bühler Motor’s engagement in their core markets within the Industrial Solutions fields:…
Klaus von Hippel, the new Product Manager of „Checkweighing Systems“ at Bize …
Balingen, 30th August 2011 - Klaus von Hippel assumed his duties as the new Product Manager of "Checkweighing Systems" at Bizerba on 01 August 2011.
Before von Hippel (42) came on board at Bizerba , he worked in product management for Ishida, an international provider of weighing and packaging solutions. Prior to that he worked for over ten years in various international sales positions for OCS-Checkweighers.
"We at Bizerba extend a…
25 years of the UNO one-hand watch – the original by Klaus Botta
In 2011, Botta-Design is celebrating 25 years since the invention of the UNO one-hand watch.
Only a handful of genuine watch-lovers and industry insiders are aware that the modern one-hand watch was the brainchild of Königstein-based designer Klaus Botta.
When the diversity of wristwatches and watch hands reached its peak in the mid-1980s, Klaus Botta felt that the readability of most watches could hardly get any worse.
To create an alternative to…
Klaus Oestreicher Lectures at the Wiesbaden International Summer University
The University of Applied Studies Wiesbaden organises the Wiesbaden International Summer University for international students in July/August 2008. Especially students from the USA and Eastern Europe are in the university’s focus.
In the globalisation process, international exchange is gaining in importance. To make this internationalisation more effective, the University of Applied Studies Wiesbaden invites foreign students to the Wiesbaden International Summer University WISU, which is directed by Prof. Dr.…
